Prot #KCP-330-006: A Phase 2, Open-label Study of the Safety and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients with Advanced Squamous Cell Carcinoma of Head and Neck, Lung, or Esophagus

  • Nimeiri, Halla S (PD/PI)

Project: Research project

Project Details

Effective start/end date4/7/154/7/18


  • Clinipace, Inc. (Prot #KCP-330-006 // Prot #KCP-330-006)
  • Karyopharm Therapeutics Inc. (Prot #KCP-330-006 // Prot #KCP-330-006)